By Michael Pollan — 2015
Research into psychedelics, shut down for decades, is now yielding exciting results.
Read on www.newyorker.com
CLEAR ALL
In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...
The drug lowers brain barriers, allowing distant regions to talk and thoughts to flow more freely.
How magic mushrooms expand consciousness.
2
The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.
1
A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.
It turns out, mystical experiences may stem from the brain letting go of inhibitions, opening a “door of perception,” the researchers found.
For a long time, research into flow states was subjective—researchers had to rely on people’s self-reported experiences to understand altered states of mind.
Ganzflicker is known to elicit the experience of anomalous sensory information in the external environment, called pseudo-hallucinations.
Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.
In mice and one person, scientists were able to reproduce the altered state often associated with ketamine by inducing certain brain cells to fire together in a slow, rhythmic fashion.